These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tay-Sachs' disease and Fabry's disease: clinical and chemical diagnosis of two metabolic eye diseases. Cotlier E Bull N Y Acad Med; 1974; 50(7):777-87. PubMed ID: 4210160 [No Abstract] [Full Text] [Related]
5. [Rare renal diseases: diagnosis and nephrological mangement of Anderson-Fabry disease]. Ranieri E G Ital Nefrol; 2009; 26(1):10. PubMed ID: 19255957 [No Abstract] [Full Text] [Related]
6. Introduction to Focus on Fabry nephropathy: biomarkers, progression, and disease severity. Warnock DG; Remuzzi G; Brenner BM; Levin A; Wanner C Clin J Am Soc Nephrol; 2010 Feb; 5(2):359. PubMed ID: 20019119 [No Abstract] [Full Text] [Related]
7. The zebra among horses: extensive abnormalities in a kidney biopsy without clinical signs of kidney disease. Fabry's disease. Oosterveld MJ; Florquin S; van den Bergh Weerman M; Vogt L Neth J Med; 2014 Jul; 72(6):331, 335. PubMed ID: 25319860 [No Abstract] [Full Text] [Related]
8. Conclusions: the lipidoses as possible lysosomal diseases or disorders of the vacuolar apparatus. Douglas SD; Sawitsky A Semin Hematol; 1972 Oct; 9(4):451-3. PubMed ID: 5082361 [No Abstract] [Full Text] [Related]
9. [Glomerular lipidosis]. Feriozzi S G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960019 [TBL] [Abstract][Full Text] [Related]
11. Cardiorenal syndrome and later-onset Fabry disease: is there a connection? Bzduch V Bratisl Lek Listy; 2007; 108(4-5):169. PubMed ID: 17694798 [No Abstract] [Full Text] [Related]
12. Double Hit of Hydroxichloroquine and Amiodarone Induced Renal Phospholipidosis in a Patient with Monoclonal Gammopathy and Sclerodermiform Syndrome: A Case Report and Review of the Literature. De la Flor JC; Rodríguez-Doyágüez P; Villa D; Zamora R; Díaz F Med Sci (Basel); 2024 May; 12(2):. PubMed ID: 38804381 [TBL] [Abstract][Full Text] [Related]
13. [Fabry's disease: a form of chronic renal disease that may be diagnosed and treated]. Herrero Calvo JA Nefrologia; 2008; 28(1):13-9. PubMed ID: 18336123 [No Abstract] [Full Text] [Related]
14. [Farber's disease (disseminated lipogranulomatosis). Clinical picture and summary of the chemical findings]. Rampini S; Clausen J Helv Paediatr Acta; 1967 Dec; 22(6):500-15. PubMed ID: 4232884 [No Abstract] [Full Text] [Related]
15. Teaching NeuroImages: neuroimaging leads to recognition of previously undiagnosed Fabry disease. Fancellu L; Deiana GA; Sechi G Neurology; 2010 Aug; 75(6):e28. PubMed ID: 20697099 [No Abstract] [Full Text] [Related]
16. Lipidomics in diagnosis of lipidoses. Wolf C; Quinn PJ Subcell Biochem; 2008; 49():567-88. PubMed ID: 18751927 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes. Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403 [TBL] [Abstract][Full Text] [Related]
18. Parapelvic cysts leading to a diagnosis of Fabry disease. Sayer JA; Haslam P; Brennan P Kidney Int; 2008 Nov; 74(10):1366. PubMed ID: 18974770 [No Abstract] [Full Text] [Related]
19. Mesangiolipidosis in Alagille syndrome--relationship with apolipoprotein A-I. Benoit G; Sartelet H; Levy E; Boule ME; Alvarez F; Abed L; Merouani A Nephrol Dial Transplant; 2007 Jul; 22(7):2072-5. PubMed ID: 17452414 [No Abstract] [Full Text] [Related]